Eslamparast T - Search Results

1

Probiotics and Nonalcoholic Fatty liver Disease.

Eslamparast T, Eghtesad S, Hekmatdoost A, Poustchi H. Eslamparast T, et al. Middle East J Dig Dis. 2013 Jul;5(3):129-36. Middle East J Dig Dis. 2013. PMID: 24829682 Free PMC article. Review.

2

Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.

Eslamparast T, Eghtesad S, Poustchi H, Hekmatdoost A. Eslamparast T, et al. World J Hepatol. 2015 Feb 27;7(2):204-12. doi: 10.4254/wjh.v7.i2.204. World J Hepatol. 2015. PMID: 25729475 Free PMC article. Review.

3

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Eslamparast T, Poustchi H, Zamani F, Sharafkhah M, Malekzadeh R, Hekmatdoost A. Eslamparast T, et al. Am J Clin Nutr. 2014 Mar;99(3):535-42. doi: 10.3945/ajcn.113.068890. Epub 2014 Jan 8. Am J Clin Nutr. 2014. PMID: 24401715 Free article. Clinical Trial.

4

Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study.

Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R, Poustchi H. Eslamparast T, et al. Br J Nutr. 2014 Aug 14;112(3):438-45. doi: 10.1017/S0007114514000919. Epub 2014 May 22. Br J Nutr. 2014. PMID: 24848793 Clinical Trial.

5

Flaxseed supplementation in non-alcoholic fatty liver disease: a pilot randomized, open labeled, controlled study.

Yari Z, Rahimlou M, Eslamparast T, Ebrahimi-Daryani N, Poustchi H, Hekmatdoost A. Yari Z, et al. Among authors: eslamparast t. Int J Food Sci Nutr. 2016 Jun;67(4):461-9. doi: 10.3109/09637486.2016.1161011. Epub 2016 Mar 17. Int J Food Sci Nutr. 2016. PMID: 26983396 Clinical Trial.

6

Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.

Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H. Hekmatdoost A, et al. Among authors: eslamparast t. Int J Food Sci Nutr. 2016 Dec;67(8):1024-9. doi: 10.1080/09637486.2016.1210101. Epub 2016 Jul 19. Int J Food Sci Nutr. 2016. PMID: 27436528

7

Egg consumption and risk of non-alcoholic fatty liver disease.

Mokhtari Z, Poustchi H, Eslamparast T, Hekmatdoost A. Mokhtari Z, et al. Among authors: eslamparast t. World J Hepatol. 2017 Apr 8;9(10):503-509. doi: 10.4254/wjh.v9.i10.503. World J Hepatol. 2017. PMID: 28443155 Free PMC article.

8

Legume intake and risk of nonalcoholic fatty liver disease.

Bahrami A, Teymoori F, Eslamparast T, Sohrab G, Hejazi E, Poustchi H, Hekmatdoost A. Bahrami A, et al. Among authors: eslamparast t. Indian J Gastroenterol. 2019 Feb;38(1):55-60. doi: 10.1007/s12664-019-00937-8. Epub 2019 Feb 22. Indian J Gastroenterol. 2019. PMID: 30796701

9

Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study.

Vahid F, Shivappa N, Hekmatdoost A, R Hebert J, Poustchi H, Shamsipour A, Eslamparast T, Meibodi M, Rahmani D. Vahid F, et al. Among authors: eslamparast t. Int J Vitam Nutr Res. 2018 Jun;88(3-4):144-150. doi: 10.1024/0300-9831/a000571. Epub 2019 Mar 19. Int J Vitam Nutr Res. 2018. PMID: 30887902

10

Nut consumption and total and cause-specific mortality: results from the Golestan Cohort Study.

Eslamparast T, Sharafkhah M, Poustchi H, Hashemian M, Dawsey SM, Freedman ND, Boffetta P, Abnet CC, Etemadi A, Pourshams A, Malekshah AF, Islami F, Kamangar F, Merat S, Brennan P, Hekmatdoost A, Malekzadeh R. Eslamparast T, et al. Int J Epidemiol. 2017 Feb 1;46(1):75-85. doi: 10.1093/ije/dyv365. Int J Epidemiol. 2017. PMID: 26946539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page